[go: up one dir, main page]

Chiou et al., 1995 - Google Patents

Kaliuretic peptide: the most potent inhibitor of Na (+)-K+ ATPase of the atrial natriuretic peptides

Chiou et al., 1995

Document ID
1917303104902981191
Author
Chiou S
Vesely D
Publication year
Publication venue
Endocrinology

External Links

Snippet

The present investigation was designed to determine whether atrial natriuretic peptides consisting of amino acids 1-30 (ie long-acting natriuretic peptide), 31-67 (vessel dilator), 79- 98 (kaliuretic peptide), and 99-126 [atrial natriuretic factor (ANF)] of the 126 amino acid ANF …
Continue reading at academic.oup.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Similar Documents

Publication Publication Date Title
Chiou et al. Kaliuretic peptide: the most potent inhibitor of Na (+)-K+ ATPase of the atrial natriuretic peptides
Christov et al. Plasma FGF23 levels increase rapidly after acute kidney injury
Gunning et al. Atrial natriuretic peptide (31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.
Kitamura et al. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney
Herzig et al. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
KAMOI et al. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus
Tsutomu et al. Elevation of plasma endothelin concentrations during endotoxin shock in dogs
Lafond et al. Parathyroid hormone receptor in human placental syncytiotrophoblast brush border and basal plasma membranes
Gutkowska et al. Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy.
Gower Jr et al. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites
Hildebrandt et al. Comparison of renal actions of urodilatin and atrial natriuretic peptide
Franz et al. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases
Ationu et al. Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide
Mimran et al. Blood pressure, renin-angiotensin system and urinary kallikrein in a case of juxtaglomerular cell tumor
Figueroa et al. Cellular localisation of atrial natriuretic factor in the human kidney
Carrithers et al. Increased urinary excretion of uroguanylin in patients with congestive heart failure
VESELY et al. Increased circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in persons with pheochromocytomas
Kuwasako et al. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension
Eckland et al. Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long–Evans rat: effect of adrenalectomy and dexamethasone
Ladenson et al. Plasma atriopeptin concentrations in hyperthyroidism, euthyroidism, and hypothyroidism: studies in man and rat
Jamal et al. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin
Heptner et al. Exocrine pancreatic function after gastrectomy: Specificity of indirect tests
Vesely et al. Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats
Apa et al. Endothelin-1 inhibits basal and human chorionic gonadotrophin-stimulated progesterone production.
Ortola et al. Endogenous ANP augments fractional excretion of Pi, Ca, and Na in rats with reduced renal mass